Examples of 'dacarbazine' in a sentence
Meaning of "dacarbazine"
Dacarbazine is a chemotherapy drug used to treat various types of cancer, including skin cancer and Hodgkin's lymphoma
Show more definitions
- An antineoplastic drug used in chemotherapy.
How to use "dacarbazine" in a sentence
Basic
Advanced
dacarbazine
Dacarbazine in isolation rarely causes neurologic dysfunction.
Examples include dacarbazine and temozolomide.
The reference treatment among active drugs is dacarbazine.
Months for dacarbazine treated patients.
Temozolomide is contraindicated in patients with hypersensitivity to it or to the similar drug dacarbazine.
All solutions of dacarbazine should be protected from light.
Temozolomide and dacarbazine.
Dacarbazine is in the alkylating agent and purine analog families of medication.
If you have had an allergic reaction to dacarbazine an anticancer medicine sometimes called.
Dacarbazine is a cytostatic agent.
The chemotherapeutic strategies have been based on the use of dacarbazine and temozolomide.
Dacarbazine is indicated for the treatment of patients with metastasized malignant melanoma.
Well the doctor said a combination of interferon and Dacarbazine.
Chemotherapy medicines, such as dacarbazine and temozolomide.
Pregnancy, lactation and patients who are hypersensitive to dacarbazine.
See also
For example, procarbazine and dacarbazine also belong to these.
In another embodiment, the triazene is dacarbazine.
Procarbazine, streptozotocin, and dacarbazine are examples of antineoplastic agents of this type.
In further embodiments, the alkylating agent is dacarbazine or cisplatin.
However, other sources list dacarbazine as nonclassical, and some include temozolomide.
The triazine-based drug may include dacarbazine.
Patients in the trabectedin and dacarbazine arms received a median of 4 and 2 cycles respectively.
The other chemotherapy medicines are doxorubicin, vinblastine and dacarbazine.
Genasense was to be used in combination with dacarbazine ( another anticancer medicine ).
In one embodiment, said cancer is not metastatic melanoma resistant to dacarbazine.
Hypersensitivity to dacarbazine DTIC.
Chemoimmunotherapy with dacarbazine and aranose combined with interferon-alpha in disseminated cutaneous melanoma.
This class of compounds includes matulane, dacarbazine and temozolomide.
Dacarbazine Platinum containing compounds,.
In one embodiment, the regimen comprises dacarbazine for the treatment of melanoma.
In a very specific embodiment, the second active agent is Dacarbazine.
Melanoma of the skin and eye, together with dacarbazine and interferon-alpha in combination chemotherapy.
In the trial, patients received either Zelboraf or another cancer drug called dacarbazine.
If you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called DTIC ).
Moreover, the CHMP was concerned that Balimek was linked to worse side effects than dacarbazine.
Dacarbazine ( DTIC ) is the only FDA-approved chemotherapy agent for the treatment of Stage IV melanoma.
For melanoma, interferon and DTIC dacarbazine were used.
Dacarbazine was approved for medical use in the United States in 1975.
Combination therapy may be performed by administering a peptide of the present invention and dacarbazine ( DTIC ).
Triazines such as dacarbazine ( DTIC ).
Examples of alkylating agents include, but are not limited to, cisplatin, cyclophosphamide, melphalan, and dacarbazine.
If veno-occlusive disease of the liver occurs, further therapy with dacarbazine is contra-indicated.
After this year, patients were treated with ABVD chemotherapy adriamycin, bleomycin, vinblastine, dacarbazine.
Doxorubicin, vinblastine and dacarbazine ( AVD ).
The patient is treated with a standard chemotherapy protocol including adriamycin, bleomycin, vinblastine, dacarbazine ( ABVD ).
Commonly used first-line chemotherapy regimens included adriamycin, bleomycin, vinblastine, and dacarbazine ABVD in 27 patients 87.
The standard chemotherapy regimen for HI includes doxorubicin, bleomycin, vinblastine, and dacarbazine ( ABVD ).
The response rate with vemurafenib was 48 % compared with 5 % for dacarbazine.
The average survival with vemurafenib was estimated to be 5.3 months, compared to 1.6 months with dacarbazine.
Examples of other alkylating agents include mitobronitol, pipbroman, temozolomide ( TMZ ), dacarbazine.
